Document is current
Any future updates will be listed below
-
Authors
Wei, Tuo http://orcid.org/0000-0002-2823-9721
Cheng, Qiang http://orcid.org/0000-0002-5213-5084
Min, Yi-Li
Olson, Eric N.
Siegwart, Daniel J. http://orcid.org/0000-0003-3823-1931
- License Information
-
More Information
Article History
Received: 20 April 2020
Accepted: 27 May 2020
First Online: 26 June 2020
Competing interests
: D.J.S., Q.C., T.W., and the Reagents of the University of Texas System have filed patent applications (PCT/US19/49552 and PCT/US19/49565) on the compositions and methods for organ-specific delivery of nucleic acids. D.J.S. is a co-founder of, and consultant to, ReCode Therapeutics, which has licensed intellectual property from UT Southwestern. Y.-L.M. is currently an employee of Vertex Pharmaceuticals. E.N.O. is a consultant for Vertex Pharmaceuticals.
